CD19 and lymphoma: In a murine model of CD19+ lymphoma, NK cells expressing both anti-CS1 CAR and anti-CD19 CAR reduced NK cell fratricide and demonstrated improved efficacy compared to anti-CD19 CAR-NK cells alone.